Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: Insights from the VA CART Program

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Percutaneous Coronary ◽

Faculty Opinions recommendation of Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1122755.579832 ◽

2008 ◽

Author(s):

Wolfgang Schoels

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction

ESC Heart Failure ◽

10.1002/ehf2.12510 ◽

2019 ◽

Vol 6 (6) ◽

pp. 1233-1242 ◽

Cited By ~ 1

Author(s):

Adam D. DeVore ◽

Eric Yow ◽

Mitchell W. Krucoff ◽

Matthew W. Sherwood ◽

Linda K. Shaw ◽

...

Keyword(s):

Coronary Disease ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

055 The INDYCE Survey. Prevalence of left ventricular systolic dysfunction in stable coronary artery disease patients: Systolic ventricular function assessment is necessary in stable CAD patients

Archives of Cardiovascular Diseases Supplements ◽

10.1016/s1878-6480(10)70057-4 ◽

2010 ◽

Vol 2 (1) ◽

pp. 18

Author(s):

Marie Christine Malergue ◽

Maxime Guenoun ◽

Franck Paganelli ◽

Patrick Jourdain ◽

Yves Alamercery ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Artery Disease ◽

Stable Cad ◽

Function Assessment

TCT-96 Impact of Beta-blocker Therapy at Discharge on Mortality in Stable Coronary Artery Disease Patients with Normal Left Ventricular Function after Percutaneous Coronary Intervention

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2014.07.125 ◽

2014 ◽

Vol 64 (11) ◽

pp. B28-B29

Author(s):

Se Hun Kang ◽

Jung-Min Ahn ◽

Hee-Soon Park ◽

Sang Soo Cheon ◽

Min Su Kim ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Intervention ◽

Left Ventricular ◽

Normal Left Ventricular Function ◽

Blocker Therapy ◽

Normal Left Ventricular ◽

Percutaneous Coronary ◽

Impact of Lipoprotein (a) Levels on Long-Term Outcomes Following Percutaneous Coronary Intervention in Patients With Left Ventricular Systolic Dysfunction

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2017.08.373 ◽

2017 ◽

Vol 23 (10) ◽

pp. S74

Author(s):

Jun Shitara ◽

Hirokazu Konishi ◽

Takatoshi Kasai ◽

Katsumi Miyauchi ◽

Shuta Tsuboi ◽

...

Keyword(s):

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Long Term Outcomes ◽

Lipoprotein A ◽

Protected percutaneous coronary intervention with Impella CP in a patient with left main disease, severe left ventricular systolic dysfunction and established hemolysis

Cardiovascular Diagnosis and Therapy ◽

10.21037/cdt.2019.02.06 ◽

2019 ◽

Vol 9 (2) ◽

pp. 194-199 ◽

Cited By ~ 2

Author(s):

Klio Konstantinou ◽

Thomas R. Keeble ◽

Paul A. Kelly ◽

Osama Alsanjari ◽

L. Christian Napp ◽

...

Keyword(s):

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Left Main ◽

Left Main Disease ◽

Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial

European Journal of Heart Failure ◽

10.1002/ejhf.88 ◽

2014 ◽

Vol 16 (6) ◽

pp. 685-691 ◽

Cited By ~ 6

Author(s):

Javaid Iqbal ◽

Renaud Fay ◽

David Adlam ◽

Iain Squire ◽

Yasir Parviz ◽

...

Keyword(s):

Myocardial Infarction ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Left Ventricular ◽

Post Myocardial Infarction ◽

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61170-8 ◽

2008 ◽

Vol 372 (9641) ◽

pp. 807-816 ◽

Cited By ~ 694

Author(s):

Kim Fox ◽

Ian Ford ◽

P Gabriel Steg ◽

Michal Tendera ◽

Roberto Ferrari

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Yearbook of Cardiology ◽

10.1016/s0145-4145(09)79536-x ◽

2009 ◽

Vol 2009 ◽

pp. 279-282

Author(s):

B.J. Gersh

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Predictors of left ventricular systolic dysfunction after primary percutaneous coronary intervention for patients with left anterior descending artery occlusion

Journal of Medicine in Scientific Research ◽

10.4103/jmisr.jmisr_89_20 ◽

2021 ◽

Vol 4 (4) ◽

pp. 294

Author(s):

MohamedE L Bordy ◽

AhmedGalal A Fattah Fahmy

Keyword(s):

Primary Percutaneous Coronary Intervention ◽

Systolic Dysfunction ◽

Coronary Intervention ◽

Artery Occlusion ◽

Left Ventricular ◽

Left Anterior Descending Artery ◽